Vaxart, Inc. Financing Cash Flow
Vaxart, Inc. (VXRT) reported Financing Cash Flow of -$217.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-06
- Vaxart, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $121.00K, a 3.20% decline year-over-year.
- Vaxart, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$338.00K.
- Vaxart, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $4.28M, a 3048.53% increase year-over-year.
- Vaxart, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$4.00K.
- Vaxart, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $15.24M, a 12.71% decline from fiscal 2022.
- Vaxart, Inc. net cash provided by (used in) financing activities for fiscal 2022 was $17.46M, a 86.12% decline from fiscal 2021.
- Vaxart, Inc. net cash provided by (used in) financing activities for fiscal 2021 was $125.80M, a 9.04% decline from fiscal 2020.
- Vaxart, Inc. net cash provided by (used in) financing activities for fiscal 2020 was $138.31M, a 766.63% increase from fiscal 2019.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $121.00K derived: 10-Q 6 month − S-1 3 month · filed 2026-08-06 | -$217.00K 10-Q · filed 2026-08-06 | $4.07M derived: sum of 3 quarters · filed 2026-08-06 | $4.06M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$338.00K S-1 · filed 2026-05-08 | $3.94M derived: sum of 2 quarters · filed 2026-05-08 | $3.94M derived: sum of 3 quarters · filed 2026-05-08 | $4.07M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $4.28M derived: S-1 12 month − 10-Q 9 month · filed 2026-05-08 | $4.28M derived: sum of 2 quarters · filed 2026-05-08 | $4.40M derived: sum of 3 quarters · filed 2026-08-06 | $4.24M S-1 · filed 2026-05-08 |
| 2025-09-30 | -$4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $121.00K derived: sum of 2 quarters · filed 2026-08-06 | -$43.00K 10-Q · filed 2025-11-13 | $93.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $125.00K derived: 10-Q 6 month − S-1 3 month · filed 2026-08-06 | -$39.00K 10-Q · filed 2026-08-06 | $97.00K derived: sum of 3 quarters · filed 2026-08-06 | $87.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$164.00K S-1 · filed 2026-05-08 | -$28.00K derived: sum of 2 quarters · filed 2026-05-08 | -$38.00K derived: sum of 3 quarters · filed 2026-05-08 | $38.20M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $136.00K derived: S-1 12 month − 10-Q 9 month · filed 2026-05-08 | $126.00K derived: sum of 2 quarters · filed 2026-05-08 | $38.37M derived: sum of 3 quarters · filed 2026-05-08 | $56.56M S-1 · filed 2026-05-08 |
| 2024-09-30 | -$10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $38.23M derived: sum of 2 quarters · filed 2025-11-13 | $56.43M 10-Q · filed 2025-11-13 | $56.36M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $38.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $56.44M 10-Q · filed 2025-08-13 | $56.37M derived: sum of 3 quarters · filed 2025-08-13 | $56.36M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $18.20M 10-Q · filed 2025-05-13 | $18.13M derived: sum of 2 quarters · filed 2025-05-13 | $18.12M derived: sum of 3 quarters · filed 2025-05-13 | $32.02M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$66.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$74.00K derived: sum of 2 quarters · filed 2025-03-20 | $13.82M derived: sum of 3 quarters · filed 2025-03-20 | $15.24M 10-K · filed 2025-03-20 |
| 2023-09-30 | -$8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $13.89M derived: sum of 2 quarters · filed 2024-11-13 | $15.31M 10-Q · filed 2024-11-13 | $23.91M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $13.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $15.32M 10-Q · filed 2024-08-08 | $23.91M derived: sum of 3 quarters · filed 2024-08-08 | $28.90M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $1.42M 10-Q · filed 2024-05-13 | $10.02M derived: sum of 2 quarters · filed 2024-05-13 | $15.00M derived: sum of 3 quarters · filed 2024-05-13 | $17.84M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $8.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $13.58M derived: sum of 2 quarters · filed 2024-03-14 | $16.42M derived: sum of 3 quarters · filed 2024-03-14 | $17.46M 10-K · filed 2024-03-14 |
| 2022-09-30 | $4.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $7.83M derived: sum of 2 quarters · filed 2023-11-02 | $8.87M 10-Q · filed 2023-11-02 | $9.37M derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | $2.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $3.88M 10-Q · filed 2023-08-03 | $4.38M derived: sum of 3 quarters · filed 2023-08-03 | $25.03M derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $1.04M 10-Q · filed 2023-05-04 | $1.54M derived: sum of 2 quarters · filed 2023-05-04 | $22.19M derived: sum of 3 quarters · filed 2023-05-04 | $59.25M derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $505.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $21.15M derived: sum of 2 quarters · filed 2023-03-15 | $58.21M derived: sum of 3 quarters · filed 2023-03-15 | $125.80M 10-K · filed 2023-03-15 |
| 2021-09-30 | $20.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $57.71M derived: sum of 2 quarters · filed 2022-11-09 | $125.30M 10-Q · filed 2022-11-09 | $130.40M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $37.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $104.66M 10-Q · filed 2022-08-08 | $109.75M derived: sum of 3 quarters · filed 2022-08-08 | $208.37M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $67.59M 10-Q · filed 2022-05-09 | $72.69M derived: sum of 2 quarters · filed 2022-05-09 | $171.31M derived: sum of 3 quarters · filed 2022-05-09 | $186.36M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $5.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $103.71M derived: sum of 2 quarters · filed 2022-02-24 | $118.77M derived: sum of 3 quarters · filed 2022-02-24 | $138.31M 10-K · filed 2022-02-24 |
| 2020-09-30 | $98.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $113.67M derived: sum of 2 quarters · filed 2021-11-04 | $133.21M 10-Q · filed 2021-11-04 | $130.99M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $15.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $34.60M 10-Q · filed 2021-08-05 | $32.37M derived: sum of 3 quarters · filed 2022-02-24 | $40.13M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $19.54M 10-Q · filed 2021-05-06 | $17.31M derived: sum of 2 quarters · filed 2022-02-24 | $25.07M derived: sum of 3 quarters · filed 2022-02-24 | $33.38M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | -$2.23M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $5.53M derived: sum of 2 quarters · filed 2022-02-24 | $13.84M derived: sum of 3 quarters · filed 2022-02-24 | $15.96M 10-K · filed 2022-02-24 |
| 2019-09-30 | $7.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $16.07M derived: sum of 2 quarters · filed 2020-11-12 | $18.19M 10-Q · filed 2020-11-12 | $17.67M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $8.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $10.43M 10-Q · filed 2020-08-06 | $9.91M derived: sum of 3 quarters · filed 2021-02-25 | $9.45M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $2.12M 10-Q · filed 2020-05-12 | $1.60M derived: sum of 2 quarters · filed 2021-02-25 | $1.14M derived: sum of 3 quarters · filed 2021-02-25 | $659.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | -$519.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$987.00K derived: sum of 2 quarters · filed 2021-02-25 | -$1.46M derived: sum of 3 quarters · filed 2021-02-25 | -$1.73M 10-K · filed 2021-02-25 |
| 2018-09-30 | -$468.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$945.00K derived: sum of 2 quarters · filed 2019-11-12 | -$1.21M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | -$477.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$742.00K 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | -$265.00K 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | $24.00K 10-K · filed 2019-02-06 | |||
| 2016-12-31 | -$100.00K 10-Q · filed 2018-02-06 | |||
| 2016-03-31 | -$100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-10 | -$100.00K derived: sum of 2 quarters · filed 2016-05-10 | -$200.00K 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-08 | -$100.00K 10-Q · filed 2016-02-08 | ||
| 2015-09-30 | -$100.00K 10-Q · filed 2015-11-06 | |||
| 2015-06-30 | -$100.00K 10-K · filed 2015-09-11 | |||
| 2014-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-11 | $26.80M 10-K · filed 2015-09-11 | ||
| 2014-03-31 | $26.80M 10-Q · filed 2015-05-08 | |||
| 2012-09-30 | -$24.48M 10-Q · filed 2012-11-08 | |||
| 2012-06-30 | -$400.00K 10-K · filed 2014-09-30 | |||
| 2011-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-14 | $138.00K derived: sum of 2 quarters · filed 2012-03-14 | $368.00K derived: sum of 3 quarters · filed 2012-08-09 | $663.00K 10-K · filed 2012-03-14 |
| 2011-09-24 | $121.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | $351.00K derived: sum of 2 quarters · filed 2012-08-09 | $646.00K 10-Q · filed 2012-11-08 | $873.00K derived: sum of 4 quarters · filed 2012-08-09 |
| 2011-06-25 | $230.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $525.00K 10-Q · filed 2012-08-09 | $752.00K derived: sum of 3 quarters · filed 2012-08-09 | -$6.17M derived: sum of 4 quarters · filed 2012-08-09 |
| 2011-03-26 | $295.00K 10-Q · filed 2012-05-10 | $522.00K derived: sum of 2 quarters · filed 2012-05-10 | -$6.40M derived: sum of 3 quarters · filed 2012-05-10 | |
| 2010-12-25 | $227.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-14 | -$6.70M derived: sum of 2 quarters · filed 2012-03-14 | -$48.18M 10-K · filed 2012-03-14 | |
| 2010-09-25 | -$6.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | -$48.41M 10-Q · filed 2011-11-02 | ||
| 2010-06-26 | -$41.48M 10-Q · filed 2011-08-03 | |||
| 2009-12-26 | -$17.50M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |